Brawley O W, Figueroa-Valles N
Office of Special Populations Research, National Cancer Institute, Bethesda, MD 20892, USA.
Semin Urol Oncol. 1998 Nov;16(4):235-40.
The National Cancer Institute (NCI) is the largest funder of prostate cancer research in the United States and indeed the world. It is sponsoring a number of studies to answer the significant questions pertinent to prostate cancer and pertinent to black men. These include studies of epidemiology; cancer prevention, screening, and control; clinical treatment; and basic science. In addition, the NCI is charged with dissemination of research findings to physicians and the lay public. The following is a description of the NCI prostate cancer research portfolio including the scientific questions being addressed and how are they being addressed.
美国国立癌症研究所(NCI)是美国乃至全球前列腺癌研究的最大资助机构。它正在资助多项研究,以解答与前列腺癌以及与黑人男性相关的重大问题。这些研究包括流行病学研究;癌症预防、筛查和控制;临床治疗;以及基础科学研究。此外,NCI还负责向医生和普通公众传播研究结果。以下是对NCI前列腺癌研究项目组合的描述,包括正在解决的科学问题以及解决这些问题的方式。